Atlas Trials

A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients

Clinical trial NCT02291744 · UNKNOWN

Trial details

NCT number
NCT02291744
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colon Cancer
Start date
2014-10-01
Primary completion
2017-10-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.